| Leasha J Strang, LSCSW | |
|
621 E Iron Ave, Salina, KS 67401-3035 | |
| (785) 833-5471 | |
| (785) 833-5447 |
| Full Name | Leasha J Strang |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 13 Years |
| Location | 621 E Iron Ave, Salina, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245528280 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4306 (Kansas) | Primary |
| Entity Name | Oasis Counseling Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932607629 PECOS PAC ID: 5193063725 Enrollment ID: O20190206002365 |
News Archive
A mechanic uses diagnostic tests to determine why your engine is making strange sounds before lifting a wrench to fix the problem.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. District Court of the District of Massachusetts has ruled in favor of Alnylam and has denied Tekmira Pharmaceuticals Corporation's motion to dismiss certain claims and motion to disqualify Alnylam's counsel in an infringement suit filed in January 2012.
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
ARIAD Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 16,000,000 shares of its common stock at $3.70 per share. The offering is expected to close on or about October 29, 2010, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 2,400,000 shares of common stock to cover over-allotments, if any.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leasha J Strang, LSCSW 621 E Iron Ave, Salina, KS 67401-3035 Ph: (785) 833-5471 | Leasha J Strang, LSCSW 621 E Iron Ave, Salina, KS 67401-3035 Ph: (785) 833-5471 |
News Archive
A mechanic uses diagnostic tests to determine why your engine is making strange sounds before lifting a wrench to fix the problem.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. District Court of the District of Massachusetts has ruled in favor of Alnylam and has denied Tekmira Pharmaceuticals Corporation's motion to dismiss certain claims and motion to disqualify Alnylam's counsel in an infringement suit filed in January 2012.
OSI Pharmaceuticals, Inc. today announced that the U.S. Patent & Trademark Office (PTO) has granted reissue patent RE41,065, replacing Tarceva's® (erlotinib) composition of matter patent (formerly No.5,747,498). The Company had applied for the reissue patent in February 2008, and on September 17, 2009 the Company had announced that the PTO had issued a "Notice of Allowance" accepting the Company's application to correct certain errors relating to the claiming of compounds, other than Tarceva, which had fallen outside of the scope of the main claim of the patent.
ARIAD Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 16,000,000 shares of its common stock at $3.70 per share. The offering is expected to close on or about October 29, 2010, subject to customary closing conditions. In addition, ARIAD has granted the underwriters a 30-day option to purchase up to 2,400,000 shares of common stock to cover over-allotments, if any.
› Verified 5 days ago
Ms. Mary Beth Mcdermott, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 809 Elmhurst Blvd, Salina, KS 67401 Phone: 785-823-6322 | |
Jane Gockel, LSCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 425 W Iron Ave, Salina, KS 67401 Phone: 785-825-0208 Fax: 785-826-9708 | |
Jeremy Corbeille, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 809 Elmhurst Blvd, Salina, KS 67401 Phone: 785-823-6322 | |
Teresa E Hernandez, LSCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 215 S Santa Fe Ave, Suite 102, Salina, KS 67401 Phone: 785-404-6065 | |
Sarah Ganser, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 809 Elmhurst Blvd, Salina, KS 67401 Phone: 785-823-6322 Fax: 785-823-3109 | |
Dan Clarence Gard, M.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 809 Elmhurst Blvd, Salina, KS 67401 Phone: 785-823-6322 Fax: 785-823-3019 | |
Catharine A Bolt, TLMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 509 E Elm St, Salina, KS 67401 Phone: 785-825-0541 Fax: 785-825-4024 |